Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model

Overview

Journal CPT Pharmacometrics Syst Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2019 Sep 12

PMID 31508894

Citations 9

Authors

Chiara Fornari

Lenka Oplustil OConnor

Carmen Pin

Aaron Smith

James W T Yates

S Y Amy Cheung

Duncan I Jodrell

Jerome T Mettetal

Teresa A Collins

Affiliations

Soon will be listed here.

Abstract

Haematological toxicity associated with cancer therapeutics is monitored by changes in blood cell count, and their primary effect is on proliferative progenitors in the bone marrow. Using observations in rat bone marrow and blood, we characterize a mathematical model that comprises cell proliferation and differentiation of the full haematopoietic phylogeny, with interacting feedback loops between lineages in homeostasis as well as following carboplatin exposure. We accurately predicted the temporal dynamics of several mature cell types related to carboplatin-induced bone marrow toxicity and identified novel insights into haematopoiesis. Our model confirms a significant degree of plasticity within bone marrow cells, with the number and type of both early progenitors and circulating cells affecting cell balance, via feedback mechanisms, through fate decisions of the multipotent progenitors. We also demonstrated cross-species translation of our predictions to patients, applying the same core model structure and considering differences in drug-dependent and physiology-dependent parameters.

Citing Articles

Are the Common Genetic 3'UTR Variants in ADME Genes Playing a Role in Tolerance of Breast Cancer Chemotherapy?.

Tecza K, Kalinowska-Herok M, Rusinek D, Zajkowicz A, Pfeifer A, Oczko-Wojciechowska M Int J Mol Sci. 2024; 25(22).

PMID: 39596349 PMC: 11594993. DOI: 10.3390/ijms252212283.

Chemotherapy-induced thrombocytopenia: literature review.

Gao A, Zhang L, Zhong D Discov Oncol. 2023; 14(1):10.

PMID: 36695938 PMC: 9877263. DOI: 10.1007/s12672-023-00616-3.

Quantitative Systems Pharmacology Modeling of Avadomide-Induced Neutropenia Enables Virtual Clinical Dose and Schedule Finding Studies.

Abbiati R, Pourdehnad M, Carrancio S, Pierce D, Kasibhatla S, McConnell M AAPS J. 2021; 23(5):103.

PMID: 34453265 PMC: 8397660. DOI: 10.1208/s12248-021-00623-8.

Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Pin C, Collins T, Gibbs M, Kimko H AAPS J. 2021; 23(4):77.

PMID: 34018069 PMC: 8137611. DOI: 10.1208/s12248-021-00580-2.

Predicting Chemotherapy-Induced Neutropenia and Granulocyte Colony-Stimulating Factor Response Using Model-Based In Vitro to Clinical Translation.

Chen W, Boras B, Sung T, Hu W, Spilker M, DArgenio D AAPS J. 2020; 22(6):143.

PMID: 33156437 PMC: 7764847. DOI: 10.1208/s12248-020-00529-x.

References

Barreto J, McCullough K, Ice L, Smith J . Antineoplastic agents and the associated myelosuppressive effects: a review. J Pharm Pract. 2014; 27(5):440-6. DOI: 10.1177/0897190014546108. View

Craig M . Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia. CPT Pharmacometrics Syst Pharmacol. 2017; 6(5):293-304. PMC: 5445232. DOI: 10.1002/psp4.12191. View

Wagers A, Weissman I . Plasticity of adult stem cells. Cell. 2004; 116(5):639-48. DOI: 10.1016/s0092-8674(04)00208-9. View

Basso-Ricci L, Scala S, Milani R, Migliavacca M, Rovelli A, Bernardo M . Multiparametric Whole Blood Dissection: A one-shot comprehensive picture of the human hematopoietic system. Cytometry A. 2017; 91(10):952-965. PMC: 5697613. DOI: 10.1002/cyto.a.23148. View

Manesso E, Teles J, Bryder D, Peterson C . Dynamical modelling of haematopoiesis: an integrated view over the system in homeostasis and under perturbation. J R Soc Interface. 2012; 10(80):20120817. PMC: 3565732. DOI: 10.1098/rsif.2012.0817. View

Camara De Souza D, Craig M, Cassidy T, Li J, Nekka F, Belair J . Transit and lifespan in neutrophil production: implications for drug intervention. J Pharmacokinet Pharmacodyn. 2017; 45(1):59-77. DOI: 10.1007/s10928-017-9560-y. View

Wang L, Wagers A . Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol. 2011; 12(10):643-55. PMC: 4040463. DOI: 10.1038/nrm3184. View

Juul S, Felderhoff-Mueser U . Epo and other hematopoietic factors. Semin Fetal Neonatal Med. 2007; 12(4):250-8. PMC: 2018740. DOI: 10.1016/j.siny.2007.01.015. View

Collins T, Hattersley M, Yates J, Clark E, Mondal M, Mettetal J . Translational Modeling of Drug-Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor. CPT Pharmacometrics Syst Pharmacol. 2017; 6(6):357-364. PMC: 5488126. DOI: 10.1002/psp4.12194. View

10.

Quartino A, Karlsson M, Lindman H, Friberg L . Characterization of endogenous G-CSF and the inverse correlation to chemotherapy-induced neutropenia in patients with breast cancer using population modeling. Pharm Res. 2014; 31(12):3390-403. DOI: 10.1007/s11095-014-1429-9. View

11.

Alberts , DORR . New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors. Oncologist. 1999; 3(1):15-34. View

12.

Patel A, Zhang Y, Fullerton J, Boelen L, Rongvaux A, Maini A . The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. 2017; 214(7):1913-1923. PMC: 5502436. DOI: 10.1084/jem.20170355. View

13.

Friberg L, Freijs A, Sandstrom M, Karlsson M . Semiphysiological model for the time course of leukocytes after varying schedules of 5-fluorouracil in rats. J Pharmacol Exp Ther. 2000; 295(2):734-40. View

14.

McGrath J, Lilley E . Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol. 2015; 172(13):3189-93. PMC: 4500358. DOI: 10.1111/bph.12955. View

15.

Zandvliet A, Schellens J, Dittrich C, Wanders J, Beijnen J, Huitema A . Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin. Br J Clin Pharmacol. 2008; 66(4):485-97. PMC: 2561111. DOI: 10.1111/j.1365-2125.2008.03230.x. View

16.

Kang K, Trosko J . Stem cells in toxicology: fundamental biology and practical considerations. Toxicol Sci. 2010; 120 Suppl 1:S269-89. DOI: 10.1093/toxsci/kfq370. View

17.

Woo S, Krzyzanski W, Jusko W . Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chemother Pharmacol. 2007; 62(1):123-33. PMC: 2671004. DOI: 10.1007/s00280-007-0582-9. View

18.

So E, Ouchi T . Decreased DNA repair activity in bone marrow due to low expression of DNA damage repair proteins. Cancer Biol Ther. 2014; 15(7):906-10. PMC: 4100991. DOI: 10.4161/cbt.28883. View

19.

Whichard Z, Sarkar C, Kimmel M, Corey S . Hematopoiesis and its disorders: a systems biology approach. Blood. 2010; 115(12):2339-47. PMC: 2845894. DOI: 10.1182/blood-2009-08-215798. View

20.

Torisawa Y, Spina C, Mammoto T, Mammoto A, Weaver J, Tat T . Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat Methods. 2014; 11(6):663-9. DOI: 10.1038/nmeth.2938. View